1: Shafiq S, Pringsheim T. Using antipsychotics for behavioral problems in children. Expert Opin Pharmacother. 2018 Aug 13:1-14. doi: 10.1080/14656566.2018.1509069. [Epub ahead of print] PubMed PMID: 30102079.
2: Dehning J, Grunze H, Walpoth-Niederwanger M, Kemmler G, Hausmann A. The use of (newer) antipsychotics in bipolar inpatients over a 17-year observation period. Int Clin Psychopharmacol. 2018 Aug 8. doi: 10.1097/YIC.0000000000000233. [Epub ahead of print] PubMed PMID: 30095482.
3: Ostuzzi G, Mazzi MA, Terlizzi S, Bertolini F, Aguglia A, Bartoli F, Bortolaso P, Callegari C, Caroleo M, Carrà G, Corbo M, D'Agostino A, Gastaldon C, Lucii C, Magliocco F, Martinotti G, Nosé M, Ostinelli EG, Papola D, Piccinelli MP, Piccoli A, Purgato M, Tabacchi T, Turrini G, Ruggeri M, Barbui C; STAR Network Investigators. Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy. PLoS One. 2018 Aug 2;13(8):e0201371. doi: 10.1371/journal.pone.0201371. eCollection 2018. PubMed PMID: 30071042.
4: Takahashi K, Nakagawasai O, Nemoto W, Odaira T, Sakuma W, Tan-No K. Antidepressant-like effect of aripiprazole via 5-HT(1A), D(1), and D(2) receptors in the prefrontal cortex of olfactory bulbectomized mice. J Pharmacol Sci. 2018 Jul 7. pii: S1347-8613(18)30108-7. doi: 10.1016/j.jphs.2018.06.006. [Epub ahead of print] PubMed PMID: 30061071.
5: Pichler EM, Kawohl W, Seifritz E, Roser P. Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report. Int J Psychiatry Med. 2018 Jul 30:91217418791455. doi: 10.1177/0091217418791455. [Epub ahead of print] PubMed PMID: 30058466.
6: Jamróz W, Kurek M, Czech A, Szafraniec J, Gawlak K, Jachowicz R. 3D printing of tablets containing amorphous aripiprazole by filaments co-extrusion. Eur J Pharm Biopharm. 2018 Jul 23. pii: S0939-6411(18)30353-9. doi: 10.1016/j.ejpb.2018.07.017. [Epub ahead of print] PubMed PMID: 30048746.
7: Schneider-Thoma J, Efthimiou O, Huhn M, Krause M, Reichelt L, Röder H, Davis JM, Salanti G, Leucht S. Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials. Lancet Psychiatry. 2018 Aug;5(8):653-663. doi: 10.1016/S2215-0366(18)30177-9. Epub 2018 Jul 2. PubMed PMID: 30042077.
8: López-Muñoz F, Shen WW, D'Ocon P, Romero A, Álamo C. A History of the Pharmacological Treatment of Bipolar Disorder. Int J Mol Sci. 2018 Jul 23;19(7). pii: E2143. doi: 10.3390/ijms19072143. Review. PubMed PMID: 30041458.
9: Ehret MJ, Davis E, Luttrell SE, Clark C. Aripiprazole Lauroxil NanoCrystal(®) Dispersion Technology (Aristada Initio(®)). Clin Schizophr Relat Psychoses. 2018 Summer;12(2):92-96. doi: 10.3371/CSRP.EHDA071918. PubMed PMID: 30040476.
10: Sepede G, Lorusso M, Spano MC, Di Nanno P, Di Iorio G, Di Giannantonio M. Efficacy and Safety of Atypical Antipsychotics in Bipolar Disorder With Comorbid Substance Dependence: A Systematic Review. Clin Neuropharmacol. 2018 Jul 21. doi: 10.1097/WNF.0000000000000297. [Epub ahead of print] PubMed PMID: 30036197.
11: D'Urso G, Anastasia A, Toscano E, Patti S, de Bartolomeis A. Aripiprazole-induced atrial fibrillation in a patient with concomitant risk factors. Exp Clin Psychopharmacol. 2018 Jul 23. doi: 10.1037/pha0000219. [Epub ahead of print] PubMed PMID: 30035575.
12: Balon R. The inexplicable rise of medication prices. Ann Clin Psychiatry. 2018 Aug;30(3):165-166. PubMed PMID: 30028889.
13: Navarro-Triviño FJ, de Jaime Ruiz P, Porras Segovia A, Garrido Torres-Puchol V. Oral Isotretinoin for the treatment of Aripiprazol-induced acneiform rash. Dermatol Ther. 2018 Jul 17:e12637. doi: 10.1111/dth.12637. [Epub ahead of print] PubMed PMID: 30019366.
14: Hattori S, Suda A, Kishida I, Miyauchi M, Shiraishi Y, Fujibayashi M, Tsujita N, Ishii C, Ishii N, Moritani T, Taguri M, Hirayasu Y. Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia. BMC Psychiatry. 2018 Jul 17;18(1):231. doi: 10.1186/s12888-018-1817-5. PubMed PMID: 30016952; PubMed Central PMCID: PMC6050702.
15: Tajiri M, Suzuki Y, Sugai T, Tsuneyama N, Someya T. Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia. PLoS One. 2018 Jul 17;13(7):e0199922. doi: 10.1371/journal.pone.0199922. eCollection 2018. PubMed PMID: 30016331; PubMed Central PMCID: PMC6049914.
16: Hard ML, Wehr AY, Du Y, Weiden PJ, Walling D, von Moltke L. Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia. J Clin Psychopharmacol. 2018 Jul 13. doi: 10.1097/JCP.0000000000000921. [Epub ahead of print] PubMed PMID: 30015676.
17: Stefatos A, Ha JN, Baranchuk A, Baldessarini RJ, Vázquez GH. Atrial Fibrillation and Injected Aripiprazole: A Case Report. Innov Clin Neurosci. 2018 Jun 1;15(5-6):43-45. PubMed PMID: 30013819; PubMed Central PMCID: PMC6040719.
18: Channing J, Mitchell M, Cortese S. Lurasidone in Children and Adolescents: Systematic Review and Case Report. J Child Adolesc Psychopharmacol. 2018 Jul 13. doi: 10.1089/cap.2018.0046. [Epub ahead of print] PubMed PMID: 30004236.
19: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501016/ PubMed PMID: 30000075.
20: Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate. Hum Psychopharmacol. 2018 Jul;33(4):e2666. doi: 10.1002/hup.2666. PubMed PMID: 29992643.